€84.0M
The round was led by Kurma Growth Opportunities Fund, Angelini Ventures, Wellington Partners, and Neva SGR.
N
Nuclidium
Nuclidium builds copper-based radiopharmaceuticals for precision cancer diagnosis and treatment.
Switzerland—Founded 2017
€84.0MTotal raised
Nuclidium is a Swiss clinical-stage biotech company developing copper-based radiopharmaceuticals for cancer diagnosis and treatment.
Founders
Leila Jaafar
Leila is the CEO and founder of Nuclidium and LinaThera, having previously founded Swiss Nuclides. Her earlier career includes engineering and management roles at Areva.
LinkedInGv
Gustav von Schulthess